PRUCALOPRIDE MEDSURGE prucalopride (as succinate) 2 mg tablet blister pack

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

prucalopride succinate, Quantity: 2.642 mg (Equivalent: prucalopride, Qty 2 mg)

Inapatikana kutoka:

Medsurge Pharma Pty Ltd

Dawa fomu:

Tablet

Tungo:

Excipient Ingredients: microcrystalline cellulose; titanium dioxide; macrogol 400; colloidal anhydrous silica; lactose monohydrate; iron oxide red; hypromellose; magnesium stearate; polysorbate 80

Njia ya uendeshaji:

Oral

Vitengo katika mfuko:

28 tablets

Dawa ya aina:

(S4) Prescription Only Medicine

Matibabu dalili:

Prucalopride is indicated for the treatment of chronic functional constipation in adults in whom laxatives fail to provide adequate relief.,? Before Prucalopride is considered patients must have tried at least two different types of laxatives from different classes (at the highest tolerated recommended doses) for at least six months, but have not had adequate relief from constipation.,? If treatment with Prucalopride is not effective within four weeks, the benefit of continuing treatment should be reconsidered.

Bidhaa muhtasari:

Visual Identification: Pink, circular, film coated tablet with 'C' debossed on one side and '12' on the other side.; Container Type: Blister Pack; Container Material: PVC/PE/PCTFE (Aclar)/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Idhini hali ya:

Registered

Idhini ya tarehe:

2022-02-04